Olinger Haydee 4

What Happened

• Haydee Olinger, a director of TransAct Technologies, had restricted stock units (RSUs) convert into 7,375 shares of common stock over four dates (Feb 27, 2026; Feb 28, 2026; Mar 1, 2026; Mar 2, 2026). The Form 4 lists these as derivative conversions (transaction code M). No exercise prices or cash amounts are reported (N/A), because these were RSU vesting/conversions rather than open‑market purchases or sales.

Key Details

• Transaction dates and quantities: 2/27/2026: 2,850 shares; 2/28/2026: 1,675 shares; 3/1/2026: 1,600 shares; 3/2/2026: 1,250 shares — total 7,375 shares.
• Transaction code: M (exercise or conversion of derivative security). Prices and dollar values: N/A (conversion of RSUs to common stock, one‑for‑one).
• Filing date: 2026-03-02 (filed timely based on the reported transaction dates).
• Shares owned after transaction: not disclosed in the filing.
• Footnotes: F1–F4 show these were RSUs granted in 2022–2025 under the company’s equity incentive plan, vesting 25% annually and converting 1:1 to common stock when vested.
• The Form shows both “acquired” (underlying shares) and “disposed” (the derivative RSU being settled) entries — the “disposed” entries reflect the RSU being converted, not a sale for cash.

Context

• This was a routine compensation event (vested RSUs converting into shares), not an open‑market purchase or sale. There is no cashless exercise/sale reported — no proceeds were listed. For retail investors, RSU vesting increases insider shareholdings but is typically part of standard compensation and not necessarily a directional signal about the insider’s view of the stock.